NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...
With plans in place to launch global pivotal testing of GH-001, its inhaled version of psychedelic mebufotenin (5-MeO-DMT), in treatment-resistant depression in 2026, GH Research plc reported the ...
Verywell Health on MSN
DMT treatment options for multiple sclerosis
DMTs slow the progression of multiple sclerosis and reduce relapse severity. Starting DMTs soon after diagnosis can help ...
Marc Dervaes journeyed to Mexico for a psychedelic drug that more military veterans are hoping will relieve their trauma.
A veteran of the Iraq and Afghanistan wars, Dervaes had one foot in the grave before contacting Ambio Life Sciences. Two ...
Scientists are searching for therapeutics that mimic the life-extending benefits of caloric restriction, exercise, and a good ...
Despite support from veterans, a push for more research and efforts to legalize the treatment, much remains unknown about ...
Tulisa Contostavlos showed off her abs in a crop top on Instagram on Wednesday. The singer, 37, showed off her abs in a tiny ...
On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, ...
The California Department of Public Health has warned consumers not to eat TRE House brand “Magic Mushroom” gummies, ...
OFFTAKE AGREEMENT FOR INFINITE LOOP INDIA WITH NIKEAWARD OF DETAILED ENGINEERING CONTRACT FOR INFINITE LOOP INDIA TO TOYO ...
GH Research's stock rallied after saying the FDA lifted a hold on its experimental depression treatment The FDA lifted its hold on GH Research's psychedelic drug, sending the company's shares soaring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback